Suppr超能文献

赖氨酰氧化酶 3 是一种双重特异性酶,参与 STAT3 的去乙酰化和去乙酰化修饰调节。

Lysyl Oxidase 3 Is a Dual-Specificity Enzyme Involved in STAT3 Deacetylation and Deacetylimination Modulation.

机构信息

Institute of Health Sciences, Chinese Academy of Sciences, Jiaotong University School of Medicine, 320 Yueyang Road, Shanghai 200031, China; Departments of Surgery and Medicine, Brown University School of Medicine, Rhode Island Hospital, Providence, RI 02903, USA.

Institute of Health Sciences, Chinese Academy of Sciences, Jiaotong University School of Medicine, 320 Yueyang Road, Shanghai 200031, China; Translational Medicine Center, Chest Hospital, Jiaotong University School of Medicine, Shanghai 200030, China.

出版信息

Mol Cell. 2017 Jan 19;65(2):296-309. doi: 10.1016/j.molcel.2016.12.002. Epub 2017 Jan 5.

Abstract

In mammalian cells, histone deacetylase (HDAC) and Sirtuin (SIRT) are two families responsible for removing acetyl groups from acetylated proteins. Here, we describe protein deacetylation coupled with deacetylimination as a function of lysyl oxidase (LOX) family members. LOX-like 3 (Loxl3) associates with Stat3 in the nucleus to deacetylate and deacetyliminate Stat3 on multiple acetyl-lysine sites. Surprisingly, Loxl3 N-terminal scavenger receptor cysteine-rich (SRCR) repeats, rather than the C-terminal oxidase catalytic domain, represent the major deacetylase/deacetyliminase activity. Loxl3-mediated deacetylation/deacetylimination disrupts Stat3 dimerization, abolishes Stat3 transcription activity, and restricts cell proliferation. In Loxl3-/- mice, Stat3 is constitutively acetylated and naive CD4 T cells are potentiated in Th17/Treg cell differentiation. When overexpressed, the SRCR repeats from other LOX family members can catalyze protein deacetylation/deacetylimination. Thus, our findings delineate a hitherto-unknown mechanism of protein deacetylation and deacetylimination catalyzed by lysyl oxidases.

摘要

在哺乳动物细胞中,组蛋白去乙酰化酶(HDAC)和 Sirtuin(SIRT)是负责从乙酰化蛋白上去除乙酰基的两个家族。在这里,我们描述了赖氨酰氧化酶(LOX)家族成员的蛋白去乙酰化和去乙酰化作用。LOX 样 3(Loxl3)与细胞核中的 Stat3 结合,对 Stat3 上的多个乙酰化赖氨酸位点进行去乙酰化和去乙酰化作用。令人惊讶的是,Loxl3 N 端的清道夫受体半胱氨酸丰富(SRCR)重复序列,而不是 C 端的氧化酶催化结构域,代表主要的去乙酰化/去乙酰化酶活性。Loxl3 介导的去乙酰化/去乙酰化作用破坏了 Stat3 二聚化,消除了 Stat3 的转录活性,并限制了细胞增殖。在 Loxl3-/- 小鼠中,Stat3 持续乙酰化,幼稚 CD4 T 细胞在 Th17/Treg 细胞分化中增强。当过度表达时,其他 LOX 家族成员的 SRCR 重复序列可以催化蛋白去乙酰化/去乙酰化作用。因此,我们的发现描绘了赖氨酰氧化酶催化的蛋白去乙酰化和去乙酰化作用的一个迄今未知的机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验